Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions

详细信息    查看全文

• 作者：Rashida Ginwala ; Emily McTish ; Chander Raman…
• 关键词：Flavonoid ; Apigenin ; Multiple sclerosis ; EAE ; Immune cells ; Dendritic cells
• 刊名：Journal of Neuroimmune Pharmacology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：11
• 期：1
• 页码：36-47
• 全文大小：6,654 KB
• 参考文献：Ali R, Nicholas RS, Muraro PA (2013) Drugs in development for relapsing multiple sclerosis. Drugs 73:625–650CrossRef PubMed
  Anandasabapathy N, Victora GD, Meredith M, Feder R, Dong B, Kluger C, Yao K, Dustin ML, Nussenzweig MC, Steinman RM, Liu K (2011) Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J Exp Med 208:1695–1705PubMedCentral CrossRef PubMed
  Axtell RC, Webb MS, Barnum SR, Raman C (2004) Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice. J Immunol 173:2928–2932CrossRef PubMed
  Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O’Farrelly C, Tubridy N, Mills KH (2009) CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 183:7602–7610CrossRef PubMed
  Gross CC, Jonuleit H, Wiendl H (2012) Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis. Eur J Immunol 42:569–572CrossRef PubMed
  Ha SK, Lee P, Park JA, Oh HR, Lee SY, Park JH, Lee EH, Ryu JH, Lee KR, Kim SY (2008) Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem Int 52:878–886CrossRef PubMed
  Jager AK, Saaby L (2011) Flavonoids and the CNS. Molecules 16:1471–1485CrossRef PubMed
  Jeong GS, Lee SH, Jeong SN, Kim YC, Kim EC (2009) Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1. Int Immunopharmacol 9:1374–1380CrossRef PubMed
  Kang HK, Ecklund D, Liu M, Datta SK (2009) Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther 11:R59PubMedCentral CrossRef PubMed
  Lassmann H, van Horssen J (2011) The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585:3715–3723CrossRef PubMed
  Lee JH, Zhou HY, Cho SY, Kim YS, Lee YS, Jeong CS (2007) Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch Pharm Res 30:1318–1327CrossRef PubMed
  Lefort EC, Blay J (2013) Apigenin and its impact on gastrointestinal cancers. Mol Nutr Food Res 57:126–144CrossRef PubMed
  Liang YC, Tsai SH, Tsai DC, Lin-Shiau SY, Lin JK (2001) Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett 496:12–18CrossRef PubMed
  Liu K, Nussenzweig MC (2010) Origin and development of dendritic cells. Immunol Rev 234:45–54CrossRef PubMed
  Manuel SL, Rahman S, Wigdahl B, Khan ZK, Jain P (2007) Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Front Biosci 12:4315–4335CrossRef PubMed
  Miean KH, Mohamed S (2001) Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49:3106–3112CrossRef PubMed
  Naves R, Singh SP, Cashman KS, Rowse AL, Axtell RC, Steinman L, Mountz JD, Steele C, De Sarno P, Raman C (2013) The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 191:2967–2977PubMedCentral CrossRef PubMed
  Ni HT, Spellman SR, Jean WC, Hall WA, Low WC (2001) Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. J Neurooncol 51:1–9CrossRef PubMed
  Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI (2007) Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol 179:7121–7127CrossRef PubMed
  Nico B, Quondamatteo F, Ribatti D, Bertossi M, Russo G, Herken R, Roncali L (1998) Ultrastructural localization of lectin binding sites in the developing brain microvasculature. Anat Embryol (Berl) 197:305–315CrossRef
  Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418–425PubMed
  Oh J, O’Connor PW (2015) Established disease-modifying treatments in relapsing-remitting multiple sclerosis. Curr Opin Neurol 28:220–229CrossRef PubMed
  Pashenkov M, Huang YM, Kostulas V, Haglund M, Soderstrom M, Link H (2001) Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124:480–492CrossRef PubMed
  Patel D, Shukla S, Gupta S (2007) Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol 30:233–245PubMed
  Plattner VE, Germann B, Neuhaus W, Noe CR, Gabor F, Wirth M (2010) Characterization of two blood
  ain barrier mimicking cell lines: distribution of lectin-binding sites and perspectives for drug delivery. Int J Pharm 387:34–41CrossRef PubMed
  Raiotach-Regue D, Grau-Lopez L, Naranjo-Gomez M, Ramo-Tello C, Pujol-Borrell R, Martinez-Caceres E, Borras FE (2012) Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur J Immunol 42:771–782CrossRef PubMed
  Renno T, Lin JY, Piccirillo C, Antel J, Owens T (1994) Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J Neuroimmunol 49:1–7CrossRef PubMed
  Rice GP, Hartung HP, Calabresi PA (2005) Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64:1336–1342CrossRef PubMed
  Rice-Evans C (2001) Flavonoid antioxidants. Curr Med Chem 8:797–807CrossRef PubMed
  Romanova D, Vachalkova A, Cipak L, Ovesna Z, Rauko P (2001) Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma 48:104–107PubMed
  Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19–34CrossRef PubMed
  Rouse M, Singh NP, Nagarkatti PS, Nagarkatti M (2013) Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells. Br J Pharmacol 169:1305–1321PubMedCentral CrossRef PubMed
  Sagar D, Foss C, El Baz R, Pomper MG, Khan ZK, Jain P (2012a) Mechanisms of dendritic cell trafficking across the blood
  ain barrier. J Neuroimmune Pharmacol 7:74–94PubMedCentral CrossRef PubMed
  Sagar D, Lamontagne A, Foss CA, Khan ZK, Pomper MG, Jain P (2012b) Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood
  ain barrier through paracellular transmigration and ERK activation. J Neuroinflammation 9:245PubMedCentral CrossRef PubMed
  Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962–978PubMedCentral CrossRef PubMed
  Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M, Nagarkatti P (2007) Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 72:1508–1521CrossRef PubMed
  Steinman L (2012) The discovery of natalizumab, a potent therapeutic for multiple sclerosis. J Cell Biol 199:413–416PubMedCentral CrossRef PubMed
  Steinman RM, Cohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142–1162PubMedCentral CrossRef PubMed
  Steinman RM, Hemmi H (2006) Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311:17–58PubMed
  Swanborg RH (2001) Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol Rev 184:129–135CrossRef PubMed
  Verbeek R, Plomp AC, van Tol EA, van Noort JM (2004) The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem Pharmacol 68:621–629CrossRef PubMed
  Verbeek R, van Tol EA, van Noort JM (2005) Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem Pharmacol 70:220–228CrossRef PubMed
  Wu GF, Laufer TM (2007) The role of dendritic cells in multiple sclerosis. Curr Neurol Neurosci Rep 7:245–252CrossRef PubMed
  Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63–66CrossRef PubMed
  Yoon MS, Lee JS, Choi BM, Jeong YI, Lee CM, Park JH, Moon Y, Sung SC, Lee SK, Chang YH, Chung HY, Park YM (2006) Apigenin inhibits immunostimulatory function of dendritic cells: implication of immunotherapeutic adjuvant. Mol Pharmacol 70:1033–1044CrossRef PubMed
  
• 作者单位：Rashida Ginwala (1)
  Emily McTish (1)
  Chander Raman (2)
  Narendra Singh (3)
  Mitzi Nagarkatti (3)
  Prakash Nagarkatti (3)
  Divya Sagar (1)
  Pooja Jain (1)
  Zafar K. Khan (1)
  
  1. Department of Microbiology and Immunology, and the Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA, 19129, USA
  2. Division of Clinical Immunology and Rheumatology, University of Alabama School of Medicine, Birmingham, AB, USA
  3. Department of Pathology, Microbiology and Immunology, University of South Carolina, Columbia, SC, USA
  
• 刊物主题：Neurosciences; Immunology; Pharmacology/Toxicology; Virology; Cell Biology;
• 出版者：Springer US
• ISSN：1557-1904

文摘

Apigenin, a natural flavonoid, found in several plants, fruits, vegetables, herbs, and spices, is known to have anti-oxidant and anti-inflammatory properties that are evident in the use of these substances for centuries as medicinal approaches to treat asthma, insomnia, Parkinson’s disease, neuralgia, and shingles. However, there is a considerable dearth of information regarding its effect on immune cells, especially dendritic cells (DC) that maintain the critical balance between an immunogenic and tolerogenic immune response, in an immunospecialized location like the central nervous system (CNS). In this paper we looked at the anti-inflammatory properties of Apigenin in restoration of immune function and the resultant decrease in neuroinflammation. In vivo, a significant reduction in severity of experimental autoimmune encephalomyelitis (EAE) progression and relapse was observed in C57BL/6 (progressive) and SJL/J (relapse-remitting) mouse models of multiple sclerosis upon treatment with Apigenin. Apigenin treated EAE mice show decreased expression of α4 integrin and CLEC12A on splenic DCs and an increased retention of immune cells in the periphery compared to untreated EAE mice. This correlated consequently with immunohistochemistry findings of decreased immune cell infiltration and reduced demyelination in the CNS. These results indicate a protective role of Apigenin against the neurodegenerative effects resulting from the entry of DC stimulated pathogenic T cells into the CNS thus implicating a potential therapy for neuroinflammatory disease. Keywords Flavonoid Apigenin Multiple sclerosis EAE Immune cells Dendritic cells